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Abstract.  Thrombin-induced accumulation of phos- 
phatidylinositol 3,4-bisphosphate (Ptdlns(3,4)P2) but 
not of PtdIns(3,4,5,)P3  is strongly correlated with the 
relocation to the cytoskeleton of 29 % of the p85o~ 
regulatory subunit of phosphoinositide 3-kinase 
(Ptdlns 3-kinase) and is accompanied by a  significant 
increase in Ptdlns 3-kinase activity in this subcellular 
fraction.  Actually, Ptdlns(3,4)P2 accumulation and 
Ptdlns 3-kinase, pp60  ~-s'~, and p125  eA~ translocations as 
well as aggregation were concomitant events occurring 
with a distinct lag after actin polymerization.  The ac- 
cumulation of Ptdlns(3,4)P2 and the relocalization of 
Ptdlns 3-kinase to the cytoskeleton were both depen- 
dent on tyrosine phosphorylation,  integrin signaling, 
and aggregation.  Furthermore,  although p85o~ was de- 
tected in anti-phosphotyrosine immunoprecipitates ob- 
tained from the cytoskeleton of thrombin-activated 
platelets,  we failed to demonstrate tyrosine phosphory- 
lation of cytoskeletal p85a.  Tyrphostin treatment 
clearly reduced its presence in this subcellular frac- 
tion,  suggesting a physical interaction of p85et with a 
phosphotyrosyl protein.  These data led us to inves- 
tigate the proteins that are able to interact with Ptdlns 
3-kinase in the cytoskeleton. We found an association 
of this enzyme with actin filaments:  this interaction 
was spontaneously restored after one cycle of actin de- 
polymerization-repolymerization  in vitro. This associ- 
ation with F-actin appeared to be at least partly in- 
direct,  since we demonstrated a thrombin-dependent 
interaction of p85tx with a proline-rich sequence of the 
tyrosine-phosphorylated cytoskeletal focal adhesion 
kinase, p125 rAK. In addition,  we show that Ptdlns 
3-kinase is significantly activated by the p125  rAK 
proline-rich sequence binding to the src homology 3 
domain of p85a subunit.  This interaction may repre- 
sent a new mechanism for Ptdlns 3-kinase activation 
at very specific areas of the cell and indicates that the 
focal contact-like areas linked to the actin filaments 
play a critical role in signaling events that occur upon 
ligand engagement of o~ro/~3 integrin and platelet ag- 
gregation evoked by thrombin. 
T 
HE accumulation  of phosphatidylinositol  3,4-bisphos- 
phate (Ptdlns(3,4)P2) m  and  Ptdlns(3,4,5)P3  in throm- 
bin-stimulated  human platelets is now well established 
(16, 24, 38, 41) and seems to be regulated  differently (38). 
However,  the exact  mechanism  of activation  of phospho- 
inositide  3-kinase  (Ptdlns  3-kinase)  in these ceils is  still 
obscure. The small G-protein rho (51), G-protein/33, subunit 
(44) protein kinase C  (PKC)  (26),  Ca  2+ (38),  as well  as 
tyrosine phosphorylation (19) may contribute to its activa- 
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tion.  Possible ways of stimulation  in other models also in- 
clude physical association with specific proteins  via the src 
homology 2 (SH2) domains or the proline-rich  regions of the 
p85 subunit. This results in a conformational  change of p85 
that appears to be transmitted  to the catalytic subunit (pll0) 
as an activation  signal (34, 37).  Since Ptdlns 3-kinase  has 
been found  to be associated with  activated  PDGF recep- 
tor (10) or pp60  v-s'~ (14), with a potentially  very important 
role in mitogenesis  (46) or oncogenic transformation  (43), 
respectively,  great  interest  has  been elicited  by its prod- 
ucts (i.e., D3-phosphorylated phosphoinositides).  Although 
their precise function  is still unknown,  these phospholipids 
have been suggested to play a role as second messengers ac- 
tivating downstream  signaling  enzymes like PKCg" isoform 
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charomyces cerevisiae protein Vps34p, Ptdlns 3-kinase and/ 
or its products have been recently suggested to play a role 
in intracellular  sorting  and down-regulating  processes in- 
volving  vesicle formation  and targeting  to the endosomal 
compartment (31). Another hypothesis  is a possible role of 
Ptdlns 3-kinase in regulating the polymerization and the or- 
ganization of actin, as suggested by the simultaneous appear- 
ance of PtdIns(3,4,5)P3 and actin polymerization of N-formyl 
peptide-stimulated human neutrophils  (9). 
In human platelets stimulated by thrombin,  PtdIns(3,4,5)P3 
production occurs very rapidly (38), whereas the accumula- 
tion of PtdIns(3,4)P2 is a late event dependent upon fibrino- 
gen binding to the integrin  receptor O~nb//~3 (38, 41, 42) and 
partly requires tyrosine phosphorylations (19, 48). Its pro- 
duction may be due to  Ptdins(3,4,5)P3  degradation  by a 
5-phosphatase (40),  to the effect of a Ptdlns(3)P 4-kinase 
(47), or to the direct action of Ptdins 3-kinase on Ptdins(4)P. 
Since accumulations  of Ptdins(3,4)P2  and  PtdIns(3,4,5)P3 
display different sensitivities  to Ca  2+, integrin  mobilization 
(38), and tyrosine phosphorylation (48), it is more likely that 
PtdIns(3,4)P2 synthesis  in platelet is due to the action of a 
4-kinase on PtdIns(3)P or to the action of PtdIns 3-kinase on 
Ptdlns(4)P,  both of which would involve Ptdins  3-kinase. 
However, we and others have previously observed a translo- 
cation of PtdIns  3-kinase to the cytoskeleton of thrombin- 
activated platelets  08, 50). It is noteworthy that an associa- 
tion of PtdIns 3-kinase with the eytoskeleton has also been 
reported in other cells (32).  In human platelets,  thrombin 
stimulation  leads to a dramatic reorganization  of the eyto- 
skeleton (15), which is possibly triggered in part by interac- 
tion of intetrin  receptors with their ligands  (21). Interest- 
ingly,  several  proteins involved  in signal  transduction  are 
found  relocated to the cytoskeleton of thrombin-activated 
platelets; among these are various enzymes of phosphoinosi- 
tide metabolism (18) and pp60  ~-"~ (7, 18). This cellular pro- 
tooncogene tyrosine kinase has been described to interact 
with Ptdins 3-kinase  in different cell types (34).  pp60  "~ is 
constitutively  present in large amounts in platelets  and may 
be responsible for the phosphorylation and the regulation of 
different enzymes (8). A potential role of this tyrosine kinase 
in the integrin-dependent  part of PtdIns 3-kinase  activation 
in platelets is thus conceivable.  In this model, thrombine in- 
duces the activation  of pp60'-'%  which is then translocated 
to the cytoskeleton after oerd/~3 integrin  receptor mobiliza- 
tion and aggregation (7). However, other non-receptor tyro- 
sine kinases whose activation  is related to integrin  signal- 
ing  and  eytoskeleton reorganization,  like  focal  adhesion 
kinase (p125~r), may also play crucial roles in platelet acti- 
vation (27). 
Taken together,  these observations point to a potentially 
important and dynamic function of the cytoskeleton in vari- 
ous signal transduction  pathways. Therefore, to determine its 
possible functional relationships,  we decided to study in de- 
tail the translocation  of PtdIns 3-kinase to the platelet cyto- 
skeleton during thrombin activation.  Interestingly,  kinetic 
studies revealed a strong correlation between the relocation 
of PtdIns  3-kinase  and the accumulation of PtdIns(3,4)P2. 
Since these events were dependent on both aggregation and 
otm//~3 integrin  receptor engagement,  our approach was to 
ask whether  PtdIns  3-kinase  activation  and  translocation 
were related to tyrosine phosphorylation promoted by inte- 
grin signaling. The data obtained indicated an important role 
for the integrin-dependent  tyrosine kinase activation;  how- 
ever,  cytoskeletal p85o~ was  not tyrosine phosphorylated. 
This observation led us to investigate the proteins that may 
interact with PtdIns 3-kinase in the cytoskeleton of activated 
platelets. We found that thrombin activation ofplatelets leads 
to the formation  of multienzymatic  complexes,  including 
PtdIns  3-kinase  and  tyrosine-phosphorylated  p125  ~c  in 
areas tightly associated with the actin filament system corre- 
sponding to focal contact-like domains. Their formation ap- 
pears to be dependent upon aggregation and is related to in- 
tegrin-dependent  tyrosine kinase activation.  In investigating 
these associations  further,  we found that a proline-rich  se- 
quence of human p125  r~K (residues 706-711) directly bound 
to  the  SH3  domain  of p85a.  Interestingly,  micromolar 
amounts  of a peptide corresponding to the proline-rich  re- 
gion of p125  rAK (706-711) increased the specific activity of 
PtdIns-3  kinase.  We therefore  propose that this interaction 
may represent a new mechanism  for PtdIns 3-kinase activa- 
tion at very specific areas (i.e.,  focal contact points).  The 
strong correlation observed between the formation  of these 
focal  adhesion-like  domains  and  the  accumulation  of 
PtdIns(3,4)P2 in this model may help to elucidate its func- 
tionai relationships  and emphasize  the dynamic role of the 
cytoskeleton in signal transduction. 
Materials and Methods 
Antibodies and Fusion Proteins 
The mouse anti-actin antibody was obtained from Amersham International 
(Buckinghamshire,  UK).  Mouse anti-p125  E°c, mouse anti-phosphotyro- 
sine 41310, and rat anti-p85c~ antibodies came from Upstate Biotechnology 
Inc. (New York). A highly specific antibody against the p85a subunit was 
kindly provided by Dr. Wateriield (Ludwig Institute for Cancer Research, 
London).  Sheep polyclonal  antiserum against pp60  c-s'r was  from Cam- 
bridge Research  Biochemicals Inc.  (Cambridge,  UK).  The mouse anti- 
phosphotyrosine 4GI0 coupled to agarose, the GST- p85c~-SI-I2 (NH2) im- 
mobilized or not on agarose, and the anti-GST antibody were from TEBU 
(Santa Cruz Biotechnulogy,  Inc., Santa Cruz, CA).  GST-p85a-SH3 was 
from PharMingen (San Diego,  CA). 
Preparation and Activation of  Platelets 
Platelet concentrates provided by the local blood bank (Centre l~gional de 
Transfusion Sanguine de Toulouse) were used to prepare platelets as previ- 
ously described (19) according to Ardlie et al. (2). For inositoi lipid analy- 
sis, platelets were labeled with 0.3 rnCi/ml 32pi (Amersham International) 
during 60 rain in Ca2+-free Tyrode's buffer (pH 6.5, 0.2  mM EGTA)  at 
37°C. After a washing step in the same buffer minus EGTA, platelets were 
resnspended in Tyrode's buffer containing 2.5 mM CaC]2 (3 ×  109 or 5  x 
l0  s cells per ml when the tetrapeptide RGDS was used) (42). In some ex- 
periments, before  the stimulation by human thrombin (Sigma  Chemical 
Co., St. Louis, MO), platelets were preincubated for 5 rain in the presence 
of  100  /~M  tyrphostin AG-213  (supplied  by  Dr.  A.  Levitzki,  Hebrew 
University,  Jerusalem, Israel) or for  15 s  with 500 t~M RGDS  (Sigma 
Chemical Co.).  Activation by thrombin was performed with shaking.  Ag- 
gregation  was followed in parallel by turbidimetry using an aggregometer 
(Chronolog,  Havertown,  PA) (3  ×  109 or 5  ×  l0  s cells per ml as indi- 
cated, 600 rpm.). 
Lipid Extraction and Analysis 
Reactions were stopped by addition of chloroform/methanol (vol/vol), and 
the lipids were extracted following a modified procedure of Bligh and Dyer 
(3). Lipids were immediately deacylated and analyzed using an HPLC tech- 
nique on a Parfisphere SAX column 0Vhatman International Ltd., UK) as 
previously  described (41). 
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Reactions were stopped, and cytoskeleton was immediately isolated by add- 
ing 1 vol of ice-cold CSK buffer containing 100 mM Tris-HCl, pH 7.4, 20 
mM EGTA, 2 mM Na3VO4, 2 ~g/ml aprotinin, 2 t~g/ml leupeptin, 1 mM 
PMSF (Sigma Chemical Co.), and 2% (vol/vol) Triton X-100 to control or 
activated platelet suspensions (33).  After a  10-rain incubation at 4°C, the 
cytoskeletai and Triton X-100-soluble fractions were separated by centrifu- 
gation (12,000 g, 10 rain, 4°C). For further use, cytoskeletons  were washed 
as described by Grondin et al. (18) and subsequently resuspended in suitable 
buffers by sonication (20 kI-Iz for 2  ×  10 s) using an ultrasonic cell dis- 
ruptor. 
Isolation of  Polymerized Actin and the Actin-Binding 
Protein-Rich Fraction 
Actin filaments  were isolated as previously  described by Payrastre  et al. 
(32). Briefly, cytoskeletons  from resting or activated platelets were solubi- 
lized in 10 ml of buffer A containing 0.6 M KI,  100 mM Pipes,  pH 6.5, 
100 mM KC1, 10 t~g/mi leupeptin, 1 mM PMSE and 100 t~M Na3VO4 for 
20 rain at 40C with gentle shaking and centrifuged at 40,000 g for 20 rain 
at 40C.  The supernatant, containing actin, was dialyzed  at 4°C  for 3 h 
against a buffer containing 10 mM Pipes,  pH 6.8,  1 mM EGTA,  2 mM 
MgCI2, 1 mM PMSE 2/~g/ml aprotinin, and 100 #M Na3VO4. Actin was 
then repolymerized, and this suspension was centrifuged at 12,000 g for 10 
rain at 4"C.  The pellet,  corresponding to actin filaments  and the actin- 
binding protein-rich fraction, was resuspended in 50 mM Tris-HCI (pH 7.3) 
and immediately used for the PtdIns 3-kinase assay or Western blotting. 
Ptdlns 3-Kinase Assay 
PtdIns 3-kinase activity was measured in a final volume of 100 t~l containing 
50 mM Tris-HCl, pH 7.4,  1.5 mM DTT, 100 mM NaCl, 0.5 mM EDTA, 
5 mM MgCl2, 5/zM ATE exogenous lipid vesicles (100 ~M phosphatidyl- 
inositol plus 200 ~M phosphatidylserine, prepared by sonication in 50 mM 
Tris-HCl, pH 7.4), and proteins from the different fractions. Reactions were 
started by adding  10 ILCi of [~/-32P]ATP (Amersham International) and 
were performed at 37"C with shaking for 10 rain. Reactions were stopped 
by adding a mixture of chloroform/methanol (vol/vol),  and lipids were ex- 
tracted and analyzed as previously  described (41). 
Immunoprecipitation and Immunopurification 
Cytoskeletons were resuspended in 1 ml ofa lysis buffer containing 40 mM 
Tris-HC1,  pH  7.4,  100  mM  NaCI,  100  mM  NaF,  10 mM  EDTA,  40 
mM Na4P2OT, 2  mM Na3VO4, 2/~g/ml aprotinin, 2  /~g/ml leupeptin,  1 
mM PMSF, 0.2% SDS, and 1% (vol/vol) Triton X-100. After sonication (20 
kHz for 2  x  10 s), shaking for 20 min, and centrifugation (12,000 g for 
10  min at 4"C),  the  soluble  fraction was  collected  and  subsequently 
precleared for 30 rain at 4°C with protein A-Sepharose CL-4B or protein 
G-Sepharose 4B fast flow, depending on the subclasses  and the origin of 
the antibodies used (Sigma Immuno Chemicals). Precleared  suspensions 
were then incubated for  120  rain at 4*C  with the different  antibodies: 
anti-phosphotyrosine antibody 4GI0 coupled to agarose, anti-p125  r~K anti- 
body (dilution 1:200), or anti-p85ct antibody (dilution 1:200). After the first 
60 rain, 50 t~l of 10% (wt/vol) protein A- or protein G-Sepharose resus- 
pended  in lysis  buffer  was  added.  The  immunoprceipitates were  then 
washed three times as described (19). With anti-phosphotyrosine immuno- 
precipitates, the phosphotyrosyl  proteins were  eluted as  previously  de- 
scribed (19). 
Gel Electrophoresis and Western Blotting 
Proteins were solubilized  in electrophoresis  sample buffer (100 mM Tris- 
HCI, pH 6.8, 15% (vol/vol) glycerol,  25 mM DTT, 3% SDS),  boiled for 
5 rain and separated on 7.5% SDS-PAGE. Proteins were then blotted onto 
nitrocellulose (Bio Pad Laboratories, Hercules,  CA) as described previ- 
ously (19). The nitrocellulose  was blocked for 60 rain at room temperature 
in 10 mM Tris-HCl, pH 8, 150 mM NaC1, 0.1% (vol/vol) Tween 20 (TBST) 
containing 5 % milk powder or 2 % BSA (Sigma Chemical Co.) when phos- 
photyrosyl proteins were analyzed.  Immunodetection was performed with 
different  antibodies as  indicated  in the figures.  Antibody reaction was 
visualized using alkaline phosphatase- or peroxidase-conjugated  secondary 
antibodies.  Nitroblue  tetrazolium  salt  and  5-bromo-4-chloro-3-indolyl- 
phosphate were used as reagents (Sigma Chemical Co.) for alkaline phos- 
phatase; the ECL chemiluminescence system  (Amersham International) 
was used for peroxidase.  Quantification  of the different  bands was per- 
formed using a densitometric analyzer (CRIS, Ramonville, France), which 
determines the pixel volume in each area. 
Overlay Assay 
Total cytoskeletons  isolated from thrombin-activated  platelets (0.7 IU/ml for 
5 rain) or immunopurifled  p125  FAx were subjected to 5-15% gradient SDS- 
PAGE and blotted onto nitrocellulose.  The nitrocellulose  was incubated 
with 1% BSA, 1% milk powder in TBST (0.1% Tween 20) for 5 h and subse- 
quently incubated overnight at 4°C in 50 mM Tris-HC1 (pH 7.5) containing 
12 mM 2-mercaptoethanol, 0.2 M NaC1, and 0.1% milk powder in the pres- 
ence of GST-p85t~-SH3,  GST-p85a-SH2 (NH2), or GST (at 15 #g/ml). 
Nitrocellulose  was then washed in TBST (0.1% Tween 20) containing 1% 
milk powder for 1 h to remove unbound material and then probed with anti- 
GST mAb as previously  described. 
Peptide Synthesis 
The peptides KPPRPG,  KVVRVG, and KPPRPG were prepared by solid- 
phase synthesis on an automated peptide synthesizer (model 430A; Applied 
Biosystem  Inc.,  Foster  City,  CA)  according  to  N-tertbutyloxycarbonyl 
(t-Boc)-amino  acids and symmetric anhydride or hydroxybenzotriazole  es- 
ter as activation chemistry. The products were removed from the resin and 
simultaneously  deprotected  by reaction with liquid anhydrous hydrofluoric 
acid in the presence of anisol and m-cresol as a cation scavenger at -5°C. 
The purity of the final products  (97%) was assessed by analytical  reverse- 
phase liquid chromatography (column Aquapore RP 300, L8, 220 ram, 4.6 
ram) and fast atom bombardment mass spectrometry  (MH+, 651.2) on a 
ZAP-HS double focusing spectrometer (VG Analytical, UK). 
Affinity Column 
The proline-rich peptide  from p125  ~Ar was  coupled to  CNBr-activated 
Sepharose 4B beads at a ratio of 4 nag of peptide per ml of activated beads 
according to the instructions provided by the manufacturer (Pharmacia LKB 
Biotechnology  Inc., Piscataway, NJ). Cytoskeletons were resuspended  in 
1 ml  of lysis  buffer  as  described for the immunoprecipitation method, 
precleared  with Sepharose  4B, and incubated or not in the presence of a 
mixture of two different mAbs to the SH3 domain of p85~ (obtained from 
Dr. Waterfieid's Laboratory and Dr. Matsuda).  50/zl of 10% (wt/vol) beads 
coupled to the peptide were added during 120 min at 4°C. The beads were 
then washed three times as described for the immunoprecipitation method, 
resuspended  in sample buffer, and separated by SDS-PAGE (7.5%).  Pro- 
teins were transferred to nitrocellulose  and probed with antibodies to p85c~. 
Assay of  Ptdlns 3-Kinase in the Presence 
of the Proline-rich Peptide  from p125  Fax 
PtdIns 3-kinase  was immunopurified  from the Triton X-100-sohlble frac- 
tion of resting platelets and was assayed essentially as previously described 
except that the final concentration of ATP was 50/~M and the exogenous 
lipid vesicles  used were  150 t~M phosphatidylinositol  4-monophosphate/ 
300 #M phosphatidylserine or 150 #M phosphatidylinositol/300 I~M phos- 
phatidylserine.  After addition of the peptide  (solubilized  in 50 mM Tris- 
HCI, pH 7.4), samples were preincubated for 10 rain at 4°C. The reaction 
was then started by adding  10 ttCi of [3,-32P]ATP and was performed at 
37°C with shaking for 5 rain. The lipids were immediately  extracted,  ana- 
lyzed,  and quantified  by HPLC (41). Under these assay conditions, Ptd- 
Ins(3)P or Ptdlns(3,4)P2  formation was linear with time for 10 rain. 
Results 
Ptdlns(3,4)Pz but Not PtdIns(3,4,5)Pj Synthesis 
Parallels Translocation of  Activated Ptdlns 3-Kinase 
to the Cytoskeleton 
We and others have previously  shown that upon thrombin 
stimulation, both p85~ and PtdIns 3-kinase activity signif- 
icantly relocate to the cytoskeleton  of human platelets (18, 
50). Quantitative immunoblotting (Fig. 1) showed that under 
resting  conditions,  p85ot was  hardly detectable  in  the 
Guinebault et al. Ptdlns 3-Kinase in Cytoskeleton of Human Platelets  833 Figure  1.  Quantitative im- 
munodetection of p85a in the 
cytoskeleton.  Cytoskeletons 
were extracted as indicated in 
Materials and Methods from 
resting (R) or thrombin-stim- 
ulated  (0.7 IU/ml  for 5  rain)  (,4) platelets.  Proteins  from  the 
cytoskeleton (CSK) and the corresponding Triton X-100-soluble 
(SOL.) fractions obtained from 1.6 x  10  s platelets were separated 
by SDS-PAGE (7.5  %) blotted onto nitrocellulose, and probed with 
the anti-p85c~ antibody. 
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cytoskeleton, whereas up to 29  :t: 9%  was translocated to 
this compartment after 5 rain of activation using 0.7 IU/ml 
thrornbin. A parallel decrease in the Triton X-100-soluble 
fraction was observed. The use of a highly specific antibody 
from Dr. Waterfield's laboratory unambiguously identified 
platelet p85 as the ot isoform (data not shown). 
In agreement with Zhang et al. (50), when PtdIns 3-kinase 
was assayed in the homogenate and in the cytoskeleton ob- 
tained from thrombin-stimulated cells,  its specific activity 
(picomoles per minute per p85c0 was increased by eightfold 
in the cytoskeleton. 
To investigate further a possible functional role for the relo- 
cation of PtdIns 3-kinase, we checked whether the kinetics 
of the production of D3-phosphorylated pbosphoinositides 
were correlated with the redistribution of the enzyme. Inter- 
estingly,  Fig. 2 shows  a striking correlation between PtdIns- 
(3,4)P2 accumulation in whole platelets,  increasing PtdIns 
3-kinase activity in the cytoskeleton, and translocation of 
p85ct to the cytoskeleton (Fig. 2, A, B, and C, respectively). 
In contrast, the PtdIns(3,4,5)P3 signal (Fig. 2 A, inset) ap- 
peared to be more rapid  than PtdIns(3,4)P2  synthesis,  as 
previously reported (24, 38). Thus, the accumulation of Ptd- 
Ins(3,4)P2  but not of PtdIns(3,4,5)P3 temporally correlated 
with the translocation of  PtdIns 3-kinase to the cytoskeleton. 
~rosine Phosphorylation,  Integrin Engagement, 
and Aggregation Are Required  for Association of 
Ptdlns 3-Kinase with the Cytoskeleton 
and  for Ptdlns(3,4)P2  Accumulation 
Thrombin-induced platelet aggregation is accompanied by 
a  number  of  biochemical  events,  among  them  pp6(Y-" 
translocation to the cytoskeleton, tyrosine phosphorylation 
of several cytoskeletal proteins, and actin polymerization. 
Fig.  3, A and B show that translocation of p85c~, pp60~-"% 
and  p125 FAr  correlated  well  and  may  be  considered  late 
events,  since they were significantly detectable only after 
30 s of stimulation. In addition, Fig. 3 B indicates that trans- 
location of p85ct,  p125 rag, and pp60  ¢-'~ to the cytoskeleton 
was not due to an artifactual trapping of  proteins during actin 
polymerization, which was very rapidly measurable. Indeed, 
the F-actin content increased about two times within 10 s of 
stimulation. Moreover, it is noteworthy that p85a, p125  ear, 
and  pp60  ~-s'~ relocalization  was  significantly  measurable 
only when 25%  of aggregation (AT max%) was  reached. 
The tetrapeptide RGDS and tyrphostin AG-213 are com- 
monly used to inhibit the binding of fibrinogen to integrin 
Ct,lb//33 receptor  and  to  inhibit  tyrosine  phosphorylation, 
respectively. Both compounds have been previously shown 
Figure 2. Comparison of  the time courses of Ptdlns 3-kinase trans- 
location and  3D-phosphorylated inositol lipids accumulation in 
whole cells upon thrombin stimulation. 32P-labeled  platelets (3  x 
109 cells/ml) were activated with 0.7 IU/ml thrombin for increas- 
ing periods of time. Reactions were stopped by addition of chloro- 
form/methanol (vol/vol). Lipids were immediately extracted and 
deacylated. [32P]PI(3,4)Pz  (e) and [32p]PI(3,4,5)P3 (o) were sub- 
sequently separated and quantified using HPLC (,4) as described 
in Materials and Methods. In parallel, platelets from the same prep- 
aration were incubated under similar conditions (1.6 x  108 cells 
per assay) and lysed by addition of CSK buffer. Cytoskeletons were 
immediately extracted and assayed for PtdIns 3-kinase activity (B) 
or analyzed for the presence of p85o~ by Western blotting (C). 
Results are expressed as percent control and are means +  SD of 
three to five independent experiments. 
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Figure 3.  Analysis and com- 
parison of different events oc- 
curring  in  cytoskeletons  of 
thrombin-stimulated platelets. 
Platelets were stimulated with 
0.7  IU/ml  thrombin  for  in- 
creasing periods of time as in- 
dicated  in  the  figure. The 
reactions were stopped by ad- 
dition  of  CSK  buffer,  and 
cytoskeletons  were  immedi- 
ately  extracted.  Cytoskeletal 
proteins  (corresponding  to 
1.6 ×  los platelets) were sepa- 
rated by SDS-PAGE (7.5%), 
blotted  onto  nitrocellulose, 
and probed with different anti- 
bodies as indicated in the fig- 
ure. Alkaline phosphatase de- 
tection was used for pp60 .... 
analysis, and the ECL system was used for p85~, p125  e~x, and actin detection (A). (B) Time course of quantitated Western blot by den- 
sitometric analysis; data are expressed as a percentage of maximal transloeation for each protein and are representative of three different 
experiments. 
to reduce significantly aggregation as well as PtdIns(3,4)P2 
accumulation induced by thrombin (19, 42). Here, we show 
that tyrphostin (Fig. 4 A) and RGDS (Fig. 4 B) were able 
to inhibit both the translocation of p85o~ to the cytoskeleton 
and  Ptdlns(3,4)P2  synthesis  (Table I),  with  RGDS  being 
somewhat more potent.  The translocation of pp60  '-'~ has 
already been shown to depend on anb//~3 mobilization (22, 
30); therefore, we used it as an internal control. Its relocal- 
ization  was  also  clearly  inhibited  by  RGDS  (Fig.  4  B), 
whereas tyrphostin had a clear but weaker inhibitory effect. 
Table I indicates that the percentage of inhibition of aggrega- 
tion (AT max %) induced by tyrphostin or RGDS varied in 
the same way as the percentage of inhibition of p85, translo- 
cation to the cytoskeleton, as well as the percentage of inhi- 
bition  of  PtdIns(3,4)P2  accumulation.  However,  RGDS 
again had a more pronounced effect on aggregation. More- 
over,  EGTA  (5  raM)  was  also  able  to  inhibit  thrombin- 
induced aggregation by 80 +  3 %, and interestingly, p85o~  re- 
localization and Ptdlns(3,4)P2 synthesis were both inhibited 
in the same range (85 5:5 %). Finally, the absence of shaking 
during thrombin stimulation abolished these events by about 
the same percentage as the inhibition observed with EGTA, 
clearly indicating that they are aggregation dependent. There- 
fore, integrin engagement, aggregation, and tyrosine phos- 
phorylation are crucial for Ptdlns(3,4)P2 accumulation as 
well as p85o~  translocation to the cytoskeleton. To investigate 
these  relationships  further,  we  have  immunopurified the 
phosphotyrosyl proteins from the cytoskeleton and probed 
them with anti-p85t~  and anti-pp60  ¢-,'~ antibodies. Interest- 
ingly, both proteins were absent in the pool of phospho- 
tyrosyl proteins obtained from the cytoskeleton of resting 
cells, whereas they were clearly detected in the immunopre- 
cipitates obtained from the cytoskeleton of thrombin-acti- 
rated platelets (Fig. 5). Again, this was inhibited in the pres- 
ence of tyrphostin. An interesting question then concerned 
the tyrosine phosphorylation state of cytoskeletal p85c~. 
Cytoskeletal Acamted Ptdlns 3-Kinase Is Not 
13~osine Phosphorylated on p85~ 
Anti-p85a immunoprecipitates were prepared from the cy- 
toskeleton of resting or thrombin-activated platelets.  The 
presence of p85ot in such immunoprecipitates was analyzed 
by PtdIns 3-kinase assay and Western blotting (Fig.  6 A). 
Both PtdIns 3-kinase activity and p85c~ were clearly detected 
in the anti-p85 immunoprecipitate obtained from the tyro- 
skeleton  of activated  platelets  (Fig.  6  A),  indicating  the 
Figure 4. Effect oftyrphostin  AG- 
213  and  RGDS on  p85c~ and 
pp60 .... reloealization. Cytoskel- 
etons were prepared from resting 
(R) or thrombin-aeti~t_ed_  (0.7 IU/ 
ml, 5 rain) (A) platelets preincu- 
bated or not with tyrphostin (100 
/~M for 5 min) (panel A) or with 
RGDS (500 ~M for 15 s) (panel 
B). Cytoskeletal proteins (corre- 
sponding to 1.6  x  l0  s platelets) 
were  separated  by  SDS-PAGE 
(7.5%),  blotted  onto nitrocellu- 
lose, and probed with anti-p85t~ 
or anti-pp60 .... antibodies as in- 
dicated in the figure. 
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on Several Platelet Responses 
Percent of inhibition  Percent of inhibition 
by tyrphostin  by RGDS 
Platelet  responses  (100/~M)  (500 #M) 
Ptdlns(3,4) P2 
synthesis  53.0 + 5.6  60.3  + 6.9 
p85 translocation 
to CSK  40.4 +  12.0  54.2 5:6.4 
Aggregation 
AT max %  39.2 +  10.5  81.5 5:0.8 
Platelets were preincubated or not with tyrphostin (100/~M) or RGDS (500/~M) 
and activated  for 5 min by thrombin as indicated in Materials and Methods. 
Ptdlns(3,4)P2  synthesis was quantified using an h.p.l.c, technique. The trans- 
location  of pg5ct to the cytoskeleton (CSK)  was detected  by Western blotting 
experiments  using  anti-p85ce antibody as a probe. Quantification  was performed 
by densitometric analysis. Platelet  aggregation was measured by turbidimetry 
using a Chronolog aggregometer (600 rev/min). Results are representative of 
three to five experiments, P  <  0.001, unpaired t test. 
validity of the procedure. When these immunoprecipitated 
proteins  were  then  probed  with  an  anti-phosphotyrosine 
mAb (Fig. 6 A, right panel), we found that p85ce present in 
the cytoskeleton of activated platelets was itself virtually not 
tyrosine phosphorylated.  However, possibly only a  small 
population of p85oe is phosphorylated. Obviously, the best 
candidate would be p85ot recovered in the anti-phosphotyro- 
sine immunoprecipitate obtained from the cytoskeleton of 
thrombin-stimulated platelets. To check this possibility, we 
first estimated, using nonlimiting amounts of antibody, the 
p85a content recovered in the anti-phosphotyrosine immu- 
noprecipitate from the  cytoskeleton of activated platelets 
(Fig. 6 B, lane 2) compared with the content of p85a recov- 
ered  in  the  anti-p85ce  immunoprecipitate  from  a  similar 
cytoskeleton (Fig. 6 B, lane 1 ). The data indicate that only 
a  subpopulation of p85ce was  recovered in  the  anti-phos- 
photyrosine immunoprecipitate.  Finally,  when the  immu- 
nopurified phosphotyrosyl proteins were then probed with 
an  anti-phosphotyrosine antibody  (Fig.  6  B,  lane  3),  no 
85-kD band could be detected, indicating that, after a 5-min 
stimulation, the pool of p85ct recovered in the anti-phospho- 
tyrosine immunoprecipitate was virtually not tyrosine phos- 
Figure 5. Detection of p85c~ and plgi0  c-s'~ in anti-phosphotyrosine 
immunoprecipitates  obtained  from  cytoskeleton  of  thrombin- 
stimulated platelets. Cytoskeletal proteins obtained from 1.5  x 
109 resting (R) or thrombin-activated (0.7 IU/ml for 5 min) plate- 
lets, preincubated (A+Tyr.) or not (A) with  100/~M tyrphostin, 
were immunopurified using the agarose-coupled anti-phosphotyro- 
sine antibody 4G10 and immunoblotted as indicated in each panel. 
phorylated. These data raised the question of the identifica- 
tion of the proteins interacting with Ptdlns 3-kinase in the 
cytoskeleton. 
Translocation of Ptdlns 3-Kinase Is Directed 
to the Actin l~lament System 
As a first attempt to localize Ptdlns 3-kinase in the cytoskele- 
ton, we performed a selective extraction procedure. By solu- 
bilizing  cytoskeleton in  potassium  iodine  followed by  in 
vitro polymerization of actin as previously described (32), 
we selectively obtained the actin filament system consisting 
of actin and actin-binding proteins. As indicated in Fig.  7, 
actin was indeed present in these fractions, with a significant 
increase in F-actin content upon thrombin stimulation.  As 
shown in Fig. 7, p85t~ was hardly detectable in the F-actin- 
rich  fraction obtained  from resting  platelets,  whereas  in 
thrombin-activated platelets, p85c~ was clearly present in the 
F-actin  fraction.  Interestingly,  p125 par and  pp6(?  -s'~ were 
also strongly present in this fraction (Fig. 7). Finally, a sig- 
nificant PtdIns 3-kinase activity was measured in the isolated 
actin filamental system of stimulated cells (Fig. 7), indicat- 
ing that both p85t~ and the catalytic subunit pll0 were asso- 
ciated with actin or with an actin-binding protein in stimu- 
Figure 6. Analysis of the state of tyrosine phosphorylation of cytoskeletal p85tx. (A) Cytoskeletal proteins obtained from 1.5  x  109 rest- 
ing (R) or thrombin-activated (0.7 IU/ml for 5 rain) (A) platelets were immunoprecipitated using the anti-p85ct antibody. The immunopre- 
cipitates were checked for the presence of PtdIns 3-kinase by measuring its lipid kinase activity and by Western blotting using anti-p85ce 
antibody or the anti-phosphotyrosine antibody 4G10 as probes as indicated in the figure. (B) Cytoskeletons obtained from 1.5  x  109 
thrombin-activated (0.7 IU/ml for 5 min) platelets were used for immunoprecipitations using the anti-p85oe  antibody (lane 1 ) or the agarose- 
coupled anti-phosphotyrosine antibody 4G10 (lanes 2 and 3). Immunoprecipitated proteins were then separated by $DS-PAGE (7.5%), 
blotted onto nitrocellulose, and probed with anti-p85ct antibody (lanes 1 and 2) or the anti-phosphotyrosine antibody 4GlO (lane 3). The 
closed arrow on the upper right corresponds to 125 kD. The open arrowhead below shows the reactivity of immunoglobulin heavy chain. 
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3-kinase was still able to bind to the actin filament system 
after one cycle of depolymerization-repolymerization  of ac- 
tin in vitro. These data do not prove a direct association of 
Ptdlns  3-kinase with actin,  since several proteins may be 
candidates to link this enzyme to the actin filament system. 
Our previous data suggested an association of p85ot with a 
cytoskeletal tyrosine-phosphorylated protein; pp60  ~-s'~ is a 
possible candidate (20). A  125-kD protein is also strongly 
recognized by anti-phosphotyrosine antibodies in the cyto- 
skeleton of activated platelets (Fig. 6 B, lane 3). Since plate- 
let  aggregation  induces  focal  contact-like  areas,  p125 wx 
may thus be a good candidate as well (36). Therefore, we in- 
vestigated the possible interactions between Ptdlns 3-kinase 
and these two non-receptor tyrosine kinases. 
Cytoskeletal Ptdlns 3-Kinase Is Associated with 
~rosine-Phosphorylated p125  vax 
Despite the use of various antibodies and methodologies, we 
were unable to demonstrate the presence of pp60  ~-''r in the 
anti-p85c~ immunoprecipitate (or the other way around) ob- 
tained from cytoskeleton (data not shown). Thus, we have 
no evidence for a direct interaction between Ptdlns 3-kinase 
and pp60  ,-sr~ in the cytoskeleton of activated platelets. 
We then prepared anti-p125  rAK immunoprecipitates from 
the cytoskeleton of resting and thrombin-stimulated plate- 
lets. They were probed with anti-phosphotyrosine and anti- 
p85ot  antibodies.  Fig.  8  shows that p125 vA~ present in the 
cytoskeleton of resting platelets was weakly phosphorylated, 
whereas significant tyrosine phosphorylation was observed 
upon thrombin stimulation. It is noteworthy that a protein 
of ,'~190  kD  was  also  recognized and  may be  a  putative 
p125rAX-binding phosphotyrosyl protein or a member of the 
focal adhesion complex. When anti-p85ot antibody was used 
as a probe, no signal appeared in the anti-p125  tax immuno- 
precipitate obtained from the cytoskeleton of resting plate- 
lets, whereas a clear and single 85-kD protein was detected 
upon thrombin stimulation. These data indicate a thrombin- 
dependent  physical  interaction  between  the  regulatory 
subunit  (p85ot)  of Ptdlns  3-klnase and  the tyrosine-phos- 
phorylated p125  FAx in the cytoskeleton of activated platelets. 
This interaction appears specific, since under similar condi- 
tions, p85a was not recovered when nonimmune IgG1 from 
mouse was used instead of the anti-p125  wx antibody (Fig. 8, 
lane  C).  Moreover,  in  agreement with our previous data 
(Fig.  6), the cytoskeletal p125rAX-associated p85ot was vir- 
tually not tyrosine phosphorylated, since no 85-kD protein 
was revealed in the anti-p125  tax immunoprecipitate with the 
anti-phosphotyrosine antibody (Fig.  8, left panel). 
Interaction of a Proline-rich Sequence of 
p125  FAr (706-711) with the SH3 Domain of  p85a as a 
New Mechanism of Ptdlns 3-Kinase Activation 
To determine the domain of interaction between p125 FAK and 
p85c~, we first investigated the potential binding of the SH2 
domain of p85ot  to the tyrosine-phosphorylated region of 
p125  FAx. Using the immobilized p85o~-SH2 (NH2) domain, 
we were unable to precipitate p125 rat significantly. More- 
Figure 7. Association of p85c~ with the actin filament system. Pro- 
teins of the F-actin-rich fraction corresponding to 8 x  l0  s resting 
or activated-platelets  were separated by SDS-PAGE  (7.5%), and ana- 
lyzed by Western blotting. The presence of actin, p85~, p125  tax, 
and pp61Y  -sr~ was checked using specific antibodies as indicated 
above each panel. 
Figure 8.  Presence of p85c~ in anti-p125  wr immunoprecipitates 
from cytoskeletons of thrombin-stimulated platelets. Anti-p125  eAK 
immunoprecipitates were prepared from cytoskeletons of 1.5  x 
109 resting (R) or thrombin-stimulated (0.7 IU/ml for 5 min) (A) 
platelets. After SDS-PAGE (7.5%), the proteins were analyzed by 
Western blotting with the anti-phosphotyrosine antibody 4GI0 or 
the anti-p85c~ antibody as indicated above  each panel. To evaluate 
the specificity of the association, a control in which nonimmune 
IgG1 from mouse was used instead of anti-p125  vat antibodies is in- 
cluded (lane C). The open arrowhead shows the position of immu- 
noglobulin heavy chain. 
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p85o~-SH2  (NH2)  to  the  immunopurified  tyrosine-phos- 
phorylated p125  tax on nitrocellulose (data not shown). These 
negative data  are  in  agreement with  the  fact that p125 ear 
does not possess the typical consensus p85-SH2 binding do- 
main  in  the  potential  tyrosine phosphate-containing  se- 
quence found near its catalytic domain. 
Another possibility was the binding of a proline-rich do- 
main of p125 FAx to the SH3 domain of p85ct.  We therefore 
synthesized a peptide, KPPRPG, corresponding to a proline- 
rich sequence of human p125 F~r (residues 706-711).  Once 
immobilized on  Sepharose beads,  this  peptide  could  sig- 
nificantly bind cytoskeletal p85t~ (Fig. 9). This direct inter- 
action  seems  to  be  specific,  since  PLC-y1,  another SH3- 
containing  enzyme  of  the  phosphoinositide  metabolism 
present in platelets,  was not found to bind to this peptide 
(data not shown). In addition, preincubation of resuspended 
cytoskeleton, obtained from activated platelets, with specific 
antibodies directed to the SH3 domain of p85t~ significantly 
prevented this association (Fig. 9, A and B, lane 3), strongly 
suggesting  that the proline-rich sequence of p125 ~Ar (701- 
711) interacts with the SH3 domains of p85ot. As a control, 
unrelated  antibodies  (nonimmune  IgG1  from  mouse  or 
mAbs directed against the EGF receptor, which is not pres- 
ent in platelets) used instead of anti-p85tx-SH3 antibodies 
were not able to reduce the association significantly (data not 
shown). Moreover, Fig. 9  C shows that the p85o~-SH3 do- 
main used as GST-p85t~-SH3 was also able to bind directly 
to the peptide KPPRPG in vitro NH2.  Fig.  10 A indicates 
that p85~-SH3 but not p85c~-SH2 (NH2) was able to bind 
in  vitro  to  the  immunopurified  p125 tax  obtained  from 
cytoskeleton of activated platelets. Since weak interactions 
may be favored in these experiments, we have done overlay 
assay in which blots of immunopurified p125 F~K (Fig.  10 B, 
lane 1 ) or total cytoskeletal proteins obtained from activated 
platelets (lanes 2 and 3) were probed with GST-p85a-SH3 
0anes 1 and 3) or with GST alone as a control (lane 2) and 
then detected with an anti-GST antibody. Under these condi- 
tions,  p85a-SH3  was  able  to  bind  to  immunopurified 
p125 rat (Fig.  10 B, lane 1) and to a  125-kD protein of the 
cytoskeleton  of  activated  platelets  that  matches  p125  F~ 
(Fig.  l0 B, lane 3).  In addition, p85ot-SH3 was found to 
bind more weakly to three other proteins (Fig. 10 B, lane 3) 
of "o93, 64, and 68 kD, which have yet to be identified. 
Finally, we assessed the effect of the binding to p85t~ of the 
proline-rich sequence of p125 rat on PtdIns 3-kinase activity. 
As shown in Fig.  11, the peptide KPPRPG significantly in- 
creased the PtdIns 3-kinase activity of immunopurified en- 
zyme by 2.5-fold. Half-maximal activation was obtained in 
the presence of 10/zM peptide. Preincubation of the enzyme 
with antibodies directed to the SH3 domain of p85a before 
addition  of the peptide  reduced this  activation by  ,o40% 
(data not shown). Finally, a control peptide, KVVRVG (Fig. 
11) or KPPRVG (data not shown),  was unable to activate 
PtdIns 3-kinase significantly under similar conditions. 
To prove definitively that the direct binding of the peptide 
is responsible for the activation of PtdIns 3-kinase, we prein- 
cubated the immunopurified enzyme with or without 50/zM 
peptide for 120 rain in lysis buffer lacking SDS, washed the 
immunocomplex twice to remove the unbound peptide, and 
finally assayed for PtdIns 3-kinase. Again, a twofold increase 
in activity was observed, indicating that the direct binding 
of the  peptide  is  responsible  for the  activation of PtdIns 
3  -kinase. 
Discussion 
In agreement with Zhang et al. (50), we have demonstrated 
that ,'-,30%  of p85ot  is translocated to the cytoskeleton of 
thrombin-stimulated platelets. The translocation of p85t~ is 
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Figure 9.  Association of the  immobilized proline-rich  sequence of p125  FAr (706-711) with the SH3 domain of p85a.  Proteins from 
cytoskeleton of resting (lane 1 ) or thrombin-activated (0.7 IU/ml for 5 rain) (lane 2) platelets were adsorbed onto Sepharose beads coupled 
to the p125  tax proline-rich region (706-711) as described in Materials and Methods. Alternatively, proteins from cytoskeleton of activated 
platelets were preincubated for 30 rain with antibodies directed to the SH3 domain of  p85ct  and then adsorbed onto Sepharose beads coupled 
to  the  p125  rat proline-rich  region  (706-711) (lane 3).  Finally, proteins  from cytoskeleton  of activated platelets  were adsorbed  to 
Sepharose beads alone as a control (lane 4). After SDS-PAGE (7.5%), the proteins adsorbed were analyzed by Western blotting with the 
anti-p85c~ antibody (A). (B) Quantification  by densitometric analysis of  the Western blot. Data are expressed in arbitrary units (pixel points) 
and are means  :1:  SEM of three different experiments. Finally, the direct binding of p85ot-SH3 to the proline-rich region of p125  ear 
(706-711) was analyzed in C  Purified GST-p85ot-SH3 was diluted in lysis buffer to 5 #g/ml and incubated for 1.5 h with Sepharose beads 
alone (lane 1 ) or with Sepharose beads coupled to the peptide (lane 2). As a control, GST alone was incubated with the Sepharose beads 
coupled to the peptide (lane 3). After extensive washing, the adsorbed proteins were analyzed by Western blotting with the anti-GST anti- 
body. Lane 4 shows the position of GST-p85c~-SH3 (37 kD) on the blot. 
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since Ptdlns 3-kinase activity was measured in the cytoskele- 
ton of activated platelets and exhibited a higher specific ac- 
tivity than in  the  homogenate.  Interestingly, Ptdlns(3,4)P2 
but not PtdIns(3,4,5)P3  synthesis paralleled the translocation 
of both p85ot and Ptdlns 3-kinase activity to the cytoskele- 
ton,  strongly  suggesting  a  relationship between these two 
events.  In  thrombin-stimulated  platelets,  PtdIns(3,4,5)P3 
is  produced  very rapidly,  whereas  Ptdlns(3,4)P2  accumu- 
lates at a  later stage (24,  38).  Although  Ptdlns(3,4)P2  has 
been shown to be a degradation product of Ptdlns(3,4,5)P3  in 
neutrophils,  Sorisky et al.  (38) have demonstrated that the 
production  of these two phospholipids  is  regulated  differ- 
ently in thrombin-stimulated platelets. In this model, in con- 
trast  to  the  Ptdlns(3,4)P2  response,  the  accumulation  of 
Ptdlns(3,4,5)P3  is  unaffected  by  Ca  2÷  or  the  tetrapeptide 
RGDS (38, 42).  Our results suggest that the redistribution 
of Ptdlns  3-kinase to  the  cytoskeleton may be of impor- 
tance for the accumulation of Ptdlns(3,4)P2.  Detailed time 
course  studies  of Ptdlns(3,4)P2  accumulation  and  Ptdlns 
3-kinase,  p125  me, and pp60  ~-'~ relocalization revealed that 
these events are in fact concomitant and significantly detect- 
able  only  when  25-30%  of aggregation  (AT  max  %)  is 
reached. Similar data have been obtained by Torti et al. (45) 
for the low molecular weight GTP-binding protein Rap2B. 
In contrast,  actin polymerization is very rapidly detected, 
since double the amount of F-actin is observed within  10 s 
of stimulation. One may note that this time course of poly- 
merization fits rather well with the Ptdlns(3,4,5)P3 signal as 
previously shown in fMLP-stimulated neutrophils (9). More- 
over, it is noteworthy that the state of actin polymerization 
may in turn  influence the phosphorylation state of several 
cytoskeletal proteins,  including  the  focal adhesion  kinase 
p125 FAr (23). 
On  the  other  hand,  we  have  previously  shown  that 
PtdIns(3,4)P2  accumulation  is  inhibited  by  RGDS  (42). 
Here we demonstrate that the redistribution of p85ot to the 
actin cytoskeleton and aggregation (AT max %) are inhibited 
in a similar manner by RGDS. In addition,  EGTA (5 raM) 
Figure  I0.  Direct binding  of p85c~-SH3 to cytoskeletal  p125  pax. 
p125  F~r was immunopurified from cytoskeleton  of thrombin-acti- 
vated platelets (0.7 IU/ml for 5 min) as described in Materials and 
Methods. The immunocomplex was then incubated in lysis buffer 
at 4"C for  1.5  h  in the  presence  of 15  t~g/ml GST-pg5c~-SH3, 
GST-p85c~-SH2 (NH2), or GST alone, as indicated in the figure. 
After two washes in lysis buffer and three washes in 50 mM Tris- 
HCI, pH 7.35, 150 mM NaC1, the adsorbed proteins were analyzed 
by Western blotting using the anti-GST antibody as a probe (,4). (B) 
Immunopurified  p125  ~a~ 0ane  1)  or  total cytoskeletal  proteins 
prepared from activated platelets (lanes 2 and 3) were resolved by 
7.5 % or 5-15 % SDS-PAGE, respectively, and blotted onto nitrocel- 
lulose for overlay assay as indicated in Materials and Methods. Pro- 
teins  on nitrocellulose  were  then  probed with  GST-pg5cz-SH3 
(lanes 1 and 3) or with GST alone (lane 2) and subsequently de- 
tected with anti-GST antibody using the ECL system. The nitrocel- 
lulose of lane 3 has then been stripped according to the procedure 
provided in the ECL kit and reprobed with the anti-p125  Far anti- 
body. The position of p125  FAr is indicated by the arrowhead. 
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Figure 11.  Activation of Ptdlns 3-kinase by the peptide containing 
the proline-rich  sequence  of p125  rAK (706-711). Immunopurified 
Ptdlns 3-kinase was assayed in the presence of increasing concen- 
trations of the peptide corresponding to the proline-rich  sequence 
of p125  r~x (KPPRPG) (e) or a control peptide with the same num- 
ber of charges (KVVRVG) (o). Products of Ptdlns 3-kinase were 
quantitated  by HPLC  as  described  in  Materials  and  Methods. 
Results are expressed as Ptdlns  3-kinase activity  relative to that 
measured  in the absence of peptide,  which was taken as  1.  The 
results shown are mean  ±  SD of  three to five different experiments. 
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hibited the association ofp85a with the cytoskeletons as well 
as the accumulation of Ptdlns(3,4)P2.  Therefore, aggrega- 
tion via the binding of adhesive proteins to their receptors, 
especially fibrinogen binding to andl3~,  is required for both 
the  production  of Ptdlns(3,4)P2  and  the  translocation  of 
Ptdlns 3-kinase and pp60 c-'~ to the actin cytoskeleton. The 
similarity both in the time course and in the sensitivity of tyr- 
phostin and RGDS  of Ptdlns(3,4)P2  synthesis and Ptdlns 
3-kinase translocation to the cytoskeleton suggests that these 
events  might be  tightly linked.  This  is  not the  case  for 
Ptdlns(3,4,5)P3  production,  which is not regulated in the 
same way (38, 48). Such a difference would be explained by 
the presence in human platelets of a Ptdlns 3-kinase activated 
by G-protein By subunits (44), which was recently identified 
in other hematopoietic cells (39). Our present data and those 
previously obtained on Glanzmann's thrombastenic platelets 
(42)  may suggest a  role  for the etnb//33-1inked actin cyto- 
skeleton in  the  compartmentalization of activated Ptdlns 
3-kinase. The inhibitory effect  of  tyrphostin that we observed 
is in agreement with the fact that when RGDS blocks the 
binding of fibrinogen and other ligands to at~b/B3, thrombin- 
induced tyrosine phosphorylation of several  substrates  is 
also blocked (11, 17). The chronology of this cascade of 
events may also explain why RGDS has a more potent inhibi- 
tory effect than tyrphostin. Thus, both fibrinogen binding to 
ot~,b/B3 and the subsequently induced tyrosine phosphoryla- 
tions  are  crucial  events  for  the  translocation  of  Ptdlns 
3-kinase  to  the  actin cytoskeleton and the production of 
Ptdlns(3,4)P2  in thrombin-stimulated platelets.  The role of 
tyrosine kinases in this mechanism is confirmed by the pres- 
ence of a fraction of p85tx in anti-phosphotyrosine immuno- 
precipitates  obtained from the cytoskeleton of thrombin- 
activated platelets. However, we have found that the pool of 
cytoskeletal p85o¢ is virtually not tyrosine phosphorylated, 
even though only a subpopulation of p85ct is recovered in the 
anti-phosphotyrosine immunoprecipitate. Furthermore, we 
were also unable to show the tyrosine phosphorylation of 
p85o~ in the Triton X-100-soluble fraction of activated plate- 
lets (data not shown). Therefore, its presence in the pool of 
phosphotyrosyl proteins is possible only if p85ct  is physi- 
cally associated with another tyrosine-phosphorylated pro- 
tein. This result stimulated us to investigate the proteins that 
may interact with Ptdlns 3-kinase in the cytoskeleton of acti- 
vated platelets.  We found that the relocalization of Ptdlns 
3-kinase and pp60 .... is preferentially directed to the actin 
filament system consisting of F-actin and actin-binding pro- 
teins. Functional Ptdlns 3-kinase is still able to bind to the 
actin filaments even  after one cycle of depolymerization- 
repolymerization of actin in vitro. Our observations are con- 
sistent with the recent data obtained by Fox et al. (13). These 
authors have observed that the Triton X-100-insoluble mem- 
brane skeleton components sedimented at 100,000 g, such 
as spectrin, vinculin, or talin, as well as pp60 .....  , pp62¢-y% 
and p21='-GAP, are redistributed to the Triton X-100-insol- 
uble low speed fraction (15,000 g) during thrombin-induced 
aggregation. In this respect, it is noteworthy that a number 
of  proteins that have been identified in the platelet membrane 
skeleton are actin-binding proteins (12, 13). Our data do not 
prove a direct association with actin, since actin-binding pro- 
teins may link Ptdlns 3-kinase to F-actin and since we found 
a population of  cytoskeletal p85ct associated with a tyrosine- 
phosphorylated protein. The kinase pp60 .... is found in the 
actin-rich fraction and has been described to interact weakly 
with Ptdlns 3-kinase in the Triton X-100-soluble fraction of 
thrombin-activated human platelets (20). Therefore, we have 
investigated such a possibility in the cytoskeleton. However, 
using both Western blot and enzymatic assays, we have failed 
to  find  a  clear  interaction  between  Ptdlns  3-kinase  and 
pp60 .... under our conditions (data  not shown).  The as- 
sociation between p85a  and src-like kinases has been de- 
scribed  in  other  models  and  seems  to  be  due  to  SH3- 
mediated interactions (35);  this mechanism might be minor 
in platelets (20). 
However,  another interesting candidate is p125 r~r, a pro- 
tein tyrosine kinase involved with integrin signaling that is 
phosphorylated and activated upon thrombin stimulation of 
platelets (27). Moreover, actin-dependent cytoskeletal inter- 
actions seem to be necessary for these events (27).  Inter- 
estingly, p125  e~x is not activated in platelets from Glanz- 
mann's  thrombasthenia  (27),  which  also  fail  to  produce 
Ptdlns(3,4)P2  (42).  Our results show both the presence of a 
tyrosine-phosphorylated form of p125  ra~ in the cytoskeleton 
of thrombin-activated platelets and an interaction between 
tyrosine-phosphorylated  p125  raK  and  non-tyrosine-phos- 
phorylated p85a  in  this  cytoskeleton.  Furthermore,  the 
amount of p85a  found associated with p125  FAr is compar- 
able to the amount of p85ot recovered in the anti-phospho- 
tyrosine immunoprecipitate. This association may therefore 
explain the presence of non-tyrosine-phosphorylated p85a 
in such immunoprecipitates and the increase in its ability to 
be precipitated with the anti-phosphotyrosine antibody after 
thrombin stimulation. It is noteworthy that the potential tyro- 
sine phosphate-containing domain found near the catalytic 
domain of p125  tax (1) does not exhibit the consensus motif 
known to bind the SH2 domain of p85a, and using different 
approaches, we were unable to demonstrate an association 
by this way. However,  two proline-rich domains (564-576 
and 694-714)  containing the PPXP motif (6, 49) are found 
in the sequence of p125  rAK (1). Here we show that a peptide 
corresponding to residues 706-711  of human p125  rat binds 
to the SH3 domain of non-tyrosine-phosphorylated p85ct. 
This binding seems to be specific, since the p85ct SH3 do- 
main was also able to bind to immunopurified p125  pA~ in vi- 
tro or to a 125-kD cytoskeletal protein that matches p125 rag 
on nitrocellulose. 
Moreover, this binding led to a  significant activation of 
Ptdlns 3-kinase. This activation possibly results from the in- 
duction of a conformational change leading to the activation 
of the p110 catalytic subunit, which is comparable to the ac- 
tivation  described  for  Ptdlns  3-kinase  by  the  tyrosine- 
phosphorylated PDGF receptor (10), IRS-1 (28) and the src 
family kinase SH3 (34).  Our data strongly suggest a  new 
mode  of Ptdlns  3-kinase  regulation in  which binding of 
proline-rich sequence of p125  ra~ (706-711)  to the SH3 do- 
main of p85a increased enzymatic activity of this lipid ki- 
nase. This mechanism is operative during thrombin-induced 
aggregation and may be important for enzyme access to its 
substrate at very specific areas of the cell (i.e., focal con- 
tacts). The role of 3D-phosphorylated phospholipids at these 
particular points has now to be investigated in detail. How- 
ever, with respect to the data published recently, it is possible 
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of actin polymerization, leading to the formation of actin 
filament bundles linked to focal contact points. 
We propose that p125  r~ is responsible, at least in part, 
for the indirect binding of Ptdlns 3-kinase to actin microfila- 
merits and plays a critical role in activating and directing this 
lipid kinase to an appropriate location.  Since we demon- 
strate here a role of aggregation, integrin receptor engage- 
ment and  subsequent  tyrosine phosphorylation in  PtdIns 
3-kinase translocation, and concomitant Ptdlns(3,4)P2  ac- 
cumulation, it is tempting to suggest that p125  FA~c may be a 
key enzyme in coupling integrin receptor  signaling with 
these events.  During the reviewing process of this manu- 
script,  Chen and Guan (4,  5)  described an interaction of 
p125  rAK with Ptdlns  3-kinase  in  fibroblasts.  Interestingly, 
this association was induced by cell adhesion to fibronectin- 
coated culture dishes (5)  or by PDGF treatment (4).  Our 
results also suggest that Ptdlns 3-kinase likely displays differ- 
ent modes of interaction with cytosketetal elements since 
only o025  % of cytoskeletal p85o~ is found associated with 
p125 tax. This  physical  interaction may  be  transient,  and 
Ptdlns 3-kinase may then be compartmentalized in other 
cytoskeletal areas possibly to be down-regulated. The pres- 
ence of the SH2 and SH3 domains as well as SH3-binding 
motifs in the p85 subunit (25) may explain the different tar- 
geting of these associations. Further work is necessary to 
identify all of the different cytoskeletal proteins with which 
Ptdlns 3-kinase may be associated and their relevant bio- 
chemical and functional relationships. 
In  conclusion,  focal  contact-like  areas  induced  upon 
thrombin stimulation of platelets, involving Ot~b/~3, p125  ~Ax, 
as well as other phosphotyrosyl proteins and actin microfila- 
merits, are very important for Ptdlns 3-kinase relocation and 
Ptdlns(3,4)P2  accumulation.  Whether  this  inositol  lipid 
may in turn play a role in stabilizing the clot remains to be 
established. 
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